| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | ALK 1 ELISA Kit; ALK1 ELISA Kit; ALP ELISA Kit; Antileukoprotease ELISA Kit; Antileukoproteinase 1 ELISA Kit; Antileukoproteinase ELISA Kit; Antileukoproteinase1 ELISA Kit; BLPI ELISA Kit; Human seminal protease inhibitor ELISA Kit; HUSI 1 ELISA Kit; HUSI ELISA Kit; HUSI I ELISA Kit; HUSI-1 ELISA Kit; MPI ELISA Kit; Mucus proteinase inhibitor ELISA Kit; Protease inhibitor WAP4 ELISA Kit; Secretory leukocyte peptidase inhibitor ELISA Kit; Secretory leukocyte protease inhibitor ELISA Kit; Seminal proteinase inhibitor ELISA Kit; SLPI ELISA Kit; SLPI_HUMAN ELISA Kit; WAP four disulfide core domain protein 4 ELISA Kit; WAP four-disulfide core domain protein 4 ELISA Kit; WAP4 ELISA Kit; WFDC4 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
secretory leukocyte protease inhibitor (SLPI) is a biological molecule commonly studied in cardiovascular research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P03973
Biological context
Researchers often monitor secretory leukocyte protease inhibitor in serum, plasma, and tissue homogenates to better understand themes such as vascular biology and endothelial function, cardiac remodeling and injury responses, and thrombosis and hemostasis. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in secretory leukocyte protease inhibitor may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, endothelial markers, coagulation-related proteins, and cardiac injury markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, secretory leukocyte protease inhibitor may also appear under names such as ALK 1 and ALK1. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that secretory leukocyte protease inhibitor participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Screening of immune-related secretory proteins linking chronic kidney disease with calcific aortic valve disease based on comprehensive bioinformatics analysis and machine learning
E Zhu,Journal of translational medicine,2023
Evaluation of the levels of secretory leukocyte protease inhibitor in the cervical mucus of women with unexplained infertility
IC Madendag,J Obstet Gynaecol Res,2020